QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Halpert, J. R. Search for Related Content PubMed Articles by Halpert, J. R.

Editor's Note James R. Halpert, Editor

(Received October 3, 2005; accepted October 3, 2005)

Drug Metabolism and Disposition has undergone many changes over the past six years in its transition to centralized manuscript processing and on-line submission. In particular, I would like to thank Rich Dodenhoff (Journals Director), Jill Filler (Managing Editor), Rhonda Frankenfield (Senior Editorial Coordinator), and Debbie Tsamoudakis (Production Coordinator) for their professionalism, dedication, and support. The team in Bethesda has made it possible for the Editor to focus almost exclusively on the scientific aspects of the journal, confident that everything else was completely under control. In this context I want to make a special acknowledgment of ASPET's Executive Officer, Dr. Christie Carrico, who has set the tone of the highest standards of professionalism and collegiality for the society and its journals. I also want to thank the other members of the Board of Publications Trustees, especially the two chairmen, Ken Harden and Brian Cox, who provide leadership, advice, and occasionally solace to the Editors. Finally, I owe a huge debt of gratitude to our Editorial Assistant, Mary Schlobohm, who has kept me and the journal on an even keel through thick and thin.

The improvements in the scientific quality of Drug Metabolism and Disposition in recent years reflect the caliber of our editorial team. I was very fortunate that three Associate Editors appointed by my predecessor, Dr. Ray Novak, were willing to continue to serve the journal for an additional six years. They are: Russell A. Prough, Arleen Rifkind, and Steven A. Wrighton. I was equally fortunate to add Stephen D. Hall, Laurence S. Kaminsky, Jeffrey C. Stevens, Kenneth E. Thummel, Donald J. Tweedie, and Garold S. Yost as Associate Editors. The combined scientific credentials, expertise, and review experience of the Associate Editors and Editorial Board Members is what attracts high quality manuscripts. I would also like to acknowledge the countless ad hoc reviewers who have devoted significant time to the journal. Finally, I want to thank the many scientists from around the world who have submitted manuscripts to Drug Metabolism and Disposition. Without your dedication to your research, there would be nothing to review or print.

As scientists we face many challenges in the coming years in terms of stagnant research funding, political pressures, and a public that is overwhelmed by all the available scientific information. I think it is more important than ever that we continue to perform rigorous science, promote the reliance of public policy on sound scientific concepts and findings, and strive to make our research understandable to the general public. I am confident that Drug Metabolism and Disposition will have outstanding leadership under its new Editor, Dr. Eric Johnson. I wish him all the best.

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Halpert, J. R. Search for Related Content PubMed Articles by Halpert, J. R.